Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ('MediPharm' or the 'Company'), a pharmaceutical company specialized in precision-based cannabinoids, today announced that leading independent proxy voting and corporate governance advisory firm Glass, Lewis & Co. LLC ('Glass Lewis') published a report on June 12, 2025 recommending that MediPharm shareholders vote the GREEN Proxy or voting instruction form FOR the Company's nominees for the Board of Directors (the 'Board') at the upcoming Annual and Special Meeting of Shareholders on June 16, 2025 (the 'Meeting').
Glass Lewis is the second independent proxy advisory firm to recommend voting for the Company's nominees for the Board, following a similar recommendation issued by Institutional Shareholder Services ('ISS') on May 30, 2025.
Vote for the Highly Qualified MediPharm Nominees
MediPharm urges shareholders to vote only using the GREEN proxy or GREEN voting instruction form in support of all of the Company's nominees and resolutions. All votes must be received no later than 3:00 p.m. (Eastern time) on Friday, June 13, 2025.
To ensure your vote is counted, shareholders are encouraged to proactively contact their broker to obtain their 16-digit control number associated with the GREEN management proxy. Once received, you can cast your vote by visiting
www.medipharmlabsagm.com
.
You may receive materials or outreach from the dissident — please disregard any such communications and vote only using the GREEN proxy in support of the Company's nominees.
About MediPharm Labs
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. MediPharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets.
In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America to hold a commercial-scale domestic Good Manufacturing Practices License for the extraction of multiple natural cannabinoids. This GMP license was the first step in the Company's current foreign drug manufacturing site registration with the US FDA.
In 2023, MediPharm acquired VIVO Cannabis Inc., which expanded MediPharm's reach to medical patients in Canada via Canna Farms medical ecommerce platform, and in Australia and Germany through Beacon Medical Australia PTY Ltd. and Beacon Medical Germany GMBH. This acquisition also included Harvest Medical Clinics in Canada which provides medical cannabis patients with Physician consultations for medical cannabis education and prescriptions.
The Company carries out its operations in compliance with all applicable laws in the countries in which it operates.
Shareholder Voting Assistance:
If you have any questions or require any assistance in executing your GREEN proxy or voting instruction form, please call Sodali & Co at:
North American Toll-Free Number: 1.888.777.2059
Outside North America, Banks, Brokers and Collect Calls: 1.289.695.3075
Email:
assistance@investor.sodali.com
North American Toll-Free Facsimile: 1.877.218.5372
For up-to-date information and assistance in voting please visit:
www.medipharmlabsagm.com
Investor Contact:
MediPharm Labs Investor Relations
Telephone: +1 416.913.7425
Email:
investors@medipharmlabs.com
Media Contact:
John Vincic
Oakstrom Advisors
+1 (647) 402-6375
john@oakstrom.com
Cautionary Note Regarding Forward-Looking Information:
This news release contains 'forward-looking information' and 'forward-looking statements' (collectively, 'forward-looking statements') within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as 'expects', or 'does not expect', 'is expected', 'anticipates' or 'does not anticipate', 'plans', 'budget', 'scheduled', 'forecasts', 'estimates', 'believes' or 'intends' or variations of such words and phrases or stating that certain actions, events or results 'may' or 'could', 'would', 'might' or 'will' be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things: timing of the Annual and Special Meeting, and any outcomes resulting from the circumstances and information cited herein. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm Labs to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs' continuous disclosure filings, available on the SEDAR+ website at
www.sedarplus.ca
. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Need $1,000 Each Month? How Much You Need to Invest in a TFSA
Written by Amy Legate-Wolfe at The Motley Fool Canada Many Canadians dream of earning $1,000 a month in passive income. For those using a Tax-Free Savings Account (TFSA), that dream is tax-free. But how much do you really need to invest to make it happen? The answer depends on which stocks you choose and how much they pay. Today, we'll look at three solid dividend-paying stocks on the TSX, and figure out how much you'd need to invest in each one to hit that $1,000 monthly goal. Goeasy (TSX:GSY) is a major player in non-prime consumer lending. It helps Canadians access credit when traditional banks say no. That includes personal loans and leasing furniture or appliances. It's been around for years and has a reputation for strong performance and rising dividends. In the first quarter of 2025, the lender posted revenue of $318 million, up 22% from the same time last year. Net income came in at $52.6 million, with earnings per share of $3.08. That's up from $2.73 in Q1 2024. The dividend stock currently trades around $155 and offers a dividend yield of 3.8%. The dividend stock has raised its dividend every year for almost a decade, and its payout ratio remains sustainable. If you're comfortable with a bit more risk for more growth, goeasy could be a strong pick. Then there's Exchange Income (TSX:EIF). It's a unique dividend stock with operations in aerospace and aviation services, as well as manufacturing. In Q1 2025, the acquisition-oriented company reported revenue of $668.3 million, up 11% year over year. However, net income dipped slightly to $9.6 million from $11.8 million in Q1 2024, mostly due to acquisition costs and some seasonal slowdowns. The dividend is paid monthly and currently yields about 4.6%. Exchange Income has a long track record of paying dividends and growing through smart acquisitions. It's not as high-growth as goeasy, but it's dependable. Finally, we have Transcontinental (TSX:TCL.A). This dividend stock used to be known for its printing business, but now it's more focused on packaging. In Q2 2025, it brought in $703 million in revenue and net earnings of $24.4 million. While print still brings in revenue, it's the packaging division that's helping the company evolve. An investment may appeal to conservative investors who prefer a lower-risk business model. The dividend has remained stable, though it hasn't shown the kind of rapid growth that goeasy offers. So how much do you really need? The short answer for a mix of the three is a total investment of $263,085 at writing. Overall, it depends on the stock. Exchange Income gets you there the fastest, while Transcontinental takes longer. Goeasy lands in the middle but offers more long-term upside. Here's how investors might want to break it down for the best passive income, earning just under $12,000 a year, at $11,563 or $963.55 each month. Company Price Dividend/yr Shares Invested Income/yr EIF $57.83 $2.64 3,500 $202,400 $9,240 TCL.A $21.16 $0.90 2,500 $52,900 $2,250 GSY $155.70 $1.46 50 $7,785 $73 Total $263,085 $11,563 Achieving a $1,000 monthly income in a TFSA isn't easy, but it's definitely possible with the right combination of high-yield stocks and a long-term mindset. Whether you focus on growth, stability, or a mix of both, knowing your numbers is the first step. Let your TFSA work smarter, not harder. The post Need $1,000 Each Month? How Much You Need to Invest in a TFSA appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends Transcontinental. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
4 hours ago
- Associated Press
Mogo Applies to Extend the Expiry Dates of Certain Warrants
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 13, 2025-- Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ('Mogo' or the 'Company'), a digital wealth and payments business, today announced that it has applied to the Toronto Stock Exchange (the 'TSX') to extend the expiry date of 1,120,371 common share purchase warrants (the 'Warrants'). The Warrants were issued pursuant to the Company's US$27.5 million Registered Direct offering in December 2021 and are currently set to expire on June 13, 2025. The Warrants consist of 101,852 warrants with an exercise price of US$16.875 per common share and 1,018,519 warrants with an exercise price of US$14.10 per common share. Each Warrant entitles the holder thereof to acquire one common share of the Company and all other terms of the Warrants will remain the same. The Company is seeking to extend the expiry date of the Warrants to June 13, 2026. No insiders of the Company hold any of the Warrants, directly or indirectly. Finalization of this extension is subject to the approval of the TSX and the warrantholders. If such approvals are obtained, this extension will be effective on the date that is ten business days from the date of this press release (the 'Effective Date'), and the Warrants cannot be exercised during the period from June 13, 2025 up to the Effective Date. About Mogo Mogo Inc. (NASDAQ:MOGO; TSX:MOGO) is a financial technology company with three distinct business lines: wealth, lending, and payments. Our mission is to provide consumers with innovative financial solutions that drive long-term financial health and success. We operate with a differentiated approach in each business, leveraging technology, behavioral science, and financial tools to create unique value propositions in our respective markets. Our wealth and lending businesses are focused on the Canadian market, where we are the only subprime consumer lender that also offers a holistic wealth and investing solution. This unique integration is designed to help consumers transition from borrowing and debt to long-term wealth building. Separately, our payments business is operated through Carta Worldwide, a wholly owned subsidiary that provides modern card issuing and processing solutions, primarily in Europe. Forward-Looking Statements This news release may contain 'forward-looking statements' within the meaning of applicable securities legislation, including statements regarding the extension of the expiry date of the Warrants, including receipt of TSX and warrantholder approval. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at the time of preparation, are inherently subject to significant business, economic and competitive uncertainties and contingencies, and may prove to be incorrect. Forward-looking statements are typically identified by words such as 'may', 'will', 'could', 'would', 'anticipate', 'believe', 'expect', 'intend', 'potential', 'estimate', 'budget', 'scheduled', 'plans', 'planned', 'forecasts', 'goals' and similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Mogo's growth, its ability to expand into new products and markets and its expectations for its future financial performance are subject to a number of conditions, many of which are outside of Mogo's control. For a description of the risks associated with Mogo's business please refer to the 'Risk Factors' section of Mogo's current annual information form, which is available at and Except as required by law, Mogo disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise. View source version on CONTACT: For further information: Craig Armitage Investor Relations [email protected] US Investor Relations Contact Lytham Partners, LLC Ben Shamsian New York | Phoenix [email protected] (646) 829-9701 KEYWORD: UNITED STATES NORTH AMERICA CANADA INDUSTRY KEYWORD: DATA MANAGEMENT TECHNOLOGY PROFESSIONAL SERVICES PAYMENTS DIGITAL CASH MANAGEMENT/DIGITAL ASSETS OTHER TECHNOLOGY DATA ANALYTICS SOFTWARE OTHER PROFESSIONAL SERVICES FINTECH FINANCE SOURCE: Mogo Inc. Copyright Business Wire 2025. PUB: 06/13/2025 08:55 PM/DISC: 06/13/2025 08:53 PM
Business Upturn
4 hours ago
- Business Upturn
Aetherium Acquisition Corp. Announces Change of Special Meeting Date
GREENWICH, Conn., June 13, 2025 (GLOBE NEWSWIRE) — Aetherium Acquisition (the 'SPAC' or the 'Company'), a publicly-traded special purpose acquisition company, today announced that its Special Meeting ('Meeting'), previously scheduled at 8:30 a.m. Eastern Time on June 13, 2025, has been postponed to 8:30 a.m. Eastern Time on June 27, 2025, and the redemption right deadline has been postponed to 5:00 p.m. Eastern Time on June 25, 2025. The record date for the Meeting remains May 9, 2025. No changes have been made to the proposals to be voted on by shareholders at the Meeting. Shareholders of the Company who have previously submitted their proxy and who do not want to change their vote do not need to take any action. On May 23, 2025, the Company filed a definitive proxy statement with the Securities and Exchange Commission (the 'SEC') and on June 3, 2025, the Company filed a revised definitive proxy statement with the SEC, each in connection with its solicitation of proxies for the Meeting. Before making any voting decision, investors and shareholders of the company are urged to read the definitive proxy statement (including any amendments or supplements thereto) and other documents the company files with the sec carefully in their entirety when they become available as they will contain important information. Investors and shareholders will be able to obtain free copies of the definitive proxy statement (including any amendments or supplements thereto) and other documents filed or that will be filed with the SEC through the web site maintained by the SEC at About Aetherium Acquisition Corp. Aetherium Acquisition Corp. is a blank check company formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Efforts to identify a prospective target business will not be limited to a particular business, industry sector, or geographical region. However, it intends to focus on companies in Asia (excluding China). Forward-looking Statements This press release contains statements that may constitute 'forward-looking statements,' including with respect to Aetherium's pursuit of an alternative business combination. No assurance can be given that Aetherium will successfully seek and consummate such an alternative business combination. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Aetherium, including those set forth in the Risk Factors section of Aetherium's public filings with the Securities and Exchange Commission. Copies are available on the SEC's website, Aetherium undertakes no obligation to update these statements for revisions or changes after the date of this release except as required by law. Participants in the Solicitation The Company and its directors, executive officers, other members of management and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies from the shareholders of the Company in connection with the Meeting. Investors and shareholders may obtain more detailed information regarding the names, affiliations and interests of the Company's directors and officers in the Proxy Statement, which may be obtained free of charge from the sources indicated above. No Offer or Solicitation This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Meeting proposals. This communication shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom. Contact: For investors: Crocker Coulson, CEO, AUM Media+1 (646) 652-7185 [email protected]; [email protected]
